Violation Tracker Parent Company Summary

Parent Company Name: 
Daiichi Sankyo
Ownership Structure: 
publicly traded
Headquartered in: 
Japan
Major Industry: 
pharmaceuticals
Specific Industry: 
pharmaceuticals
Penalty total since 2000: 
$92,097,967
Number of records: 
6
Top 5 Offense Groups (Groups Defined)Penalty TotalNumber of Records
government-contracting-related offenses$78,000,0002
employment-related offenses$8,200,0001
competition-related offenses$5,897,9673
Top 5 Primary Offense TypesPenalty TotalNumber of Records
False Claims Act and related$78,000,0002
employment discrimination$8,200,0001
price-fixing or anti-competitive practices$5,897,9673
Notes: 

Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.

Associated Names: 

Daiichi Pharmaceutical; Daiichi Sankyo

Links: 

Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found here.


Individual Penalty Records:

Click on the company or penalty amount for more information on each case.
Download results as CSV or XML
Company Primary Offense Type Year Agency Penalty Amountsort icon
Daiichi Sankyo Inc. False Claims Act and related 2015 DOJ_CIVIL $39,000,000
Daiichi Sankyo, Inc. False Claims Act and related 2015 MULTI-AG $39,000,000
Daiichi Sankyo employment discrimination 2016 private lawsuit-federal $8,200,000
Daiichi Pharmaceutical price-fixing or anti-competitive practices 2000 MULTI-AG $4,340,100
Daiichi Pharmaceutical price-fixing or anti-competitive practices 2000 CA-AG $1,446,700
Daiichi Pharmaceutical price-fixing or anti-competitive practices 2002 MA-AG $111,167
Download results as CSV or XML